盈康生命(300143.SZ):擬出售長春盈康100%股權及相關債權予盈康醫投
格隆匯8月9日丨盈康生命(300143.SZ)公佈,鑑於公司下屬子公司長春盈康醫院有限公司(“長春盈康”)現有牀位數和資源無法承接公司“1+N”的物聯網區域旗艦醫療中心戰略,尚需要長期的資金投入和能力建設,與公司現階段快速建設“1-3-6”生態網絡的目標不契合。
經審慎評估,公司全資子公司星瑪康醫療科技(成都)有限公司(“星瑪康”)擬將其持有的長春盈康100%股權、公司擬將其對長春盈康享有的債權出售予公司控股股東青島盈康醫療投資有限公司(“盈康醫投”),由盈康醫投負責長春盈康後續的經營和孵化,同時盈康醫投承諾將積極解決和避免同業競爭問題。
交易完成後,星瑪康將不再持有長春盈康的股權,長春盈康將不再納入公司合併範圍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.